Yanan Cui

897 total citations
44 papers, 573 citations indexed

About

Yanan Cui is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yanan Cui has authored 44 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Yanan Cui's work include Cancer Immunotherapy and Biomarkers (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Yanan Cui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Yanan Cui collaborates with scholars based in China, United States and Australia. Yanan Cui's co-authors include Yan Chen, Pengpeng Zhang, Lianmin Zhang, Lijuan Luo, Zhenfa Zhang, Yiming Ma, Renhua Guo, Xiangming Liu, Yabin Wang and Zihang Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and ACS Applied Materials & Interfaces.

In The Last Decade

Yanan Cui

38 papers receiving 566 citations

Peers

Yanan Cui
Yanan Cui
Citations per year, relative to Yanan Cui Yanan Cui (= 1×) peers Noëlla Germain

Countries citing papers authored by Yanan Cui

Since Specialization
Citations

This map shows the geographic impact of Yanan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Cui more than expected).

Fields of papers citing papers by Yanan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Cui. The network helps show where Yanan Cui may publish in the future.

Co-authorship network of co-authors of Yanan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Cui. A scholar is included among the top collaborators of Yanan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Cui. Yanan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cui, Yanan, Z. L. Hou, J. Jean Cui, et al.. (2025). Naringenin Inhibits Enterotoxigenic Escherichia coli-Induced Ferroptosis via Targeting HSP90 in IPEC-J2 Cells. Antioxidants. 14(8). 914–914.
4.
Liu, Lisheng, et al.. (2024). Tumor-exosomal miR-205-5p as a diagnostic biomarker for colorectal cancer. Clinical & Translational Oncology. 27(3). 1185–1197. 2 indexed citations
5.
Tang, Xingyao, Ke Huang, Tingting Huang, et al.. (2024). Relationship between diabetes-related clinical characteristics and preserved ratio impaired spirometry (PRISm): findings from NHANES 2007–2012. SHILAP Revista de lepidopterología. 2(2). e001313–e001313. 2 indexed citations
6.
Xiao, Liang, Jiali Xu, Hongshuai Wu, et al.. (2024). Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer. Molecular Carcinogenesis. 63(9). 1643–1653. 2 indexed citations
7.
Zhang, Lianmin, Yanan Cui, Jie Mei, Zhenfa Zhang, & Pengpeng Zhang. (2024). Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies. Cell Proliferation. 57(11). e13703–e13703. 29 indexed citations
10.
Zhang, Pengpeng, et al.. (2023). Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature. Frontiers in Immunology. 14. 1244144–1244144. 20 indexed citations
11.
Cui, Yanan, et al.. (2023). Potential value of efficacy prediction and treatment of natural killer cells in extensive stage small cell lung cancer. Thoracic Cancer. 14(10). 864–872. 1 indexed citations
12.
Xiao, Liang, Runwei Guan, Jiamin Zhu, et al.. (2023). A clinical decision support system to predict the efficacy for EGFR-TKIs based on artificial neural network. Journal of Cancer Research and Clinical Oncology. 149(13). 12265–12274. 6 indexed citations
13.
Cui, Yanan, Jun Li, Pengpeng Zhang, et al.. (2023). B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 41 indexed citations
14.
Cui, Yanan, Liang Xiao, Jiali Xu, et al.. (2023). PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers. Frontiers in Genetics. 13. 1066347–1066347. 12 indexed citations
17.
Cui, Yanan, et al.. (2022). Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. Frontiers in Oncology. 12. 798401–798401. 8 indexed citations
18.
Chen, Wenjie, et al.. (2021). Next generation sequencing in children with unexplained epilepsy: A retrospective cohort study. Brain and Development. 43(10). 1004–1012. 5 indexed citations
19.
Zhang, Shuang, et al.. (2021). Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer. Frontiers in Oncology. 11. 696010–696010. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026